Patents Examined by David Thomas
  • Patent number: 9297038
    Abstract: Disclosed are a method and a kit for the quantification of nucleic acids, especially a trace amount of nucleic acid, such as host cell nucleic acid impurities, using real-time PCR with a random primer.
    Type: Grant
    Filed: November 9, 2011
    Date of Patent: March 29, 2016
    Assignee: KOREA RESEARCH INSTITUTE OF STANDARDS AND SCIENCE
    Inventors: In Chul Yang, Min Jung Kang, Han Nah Yu, Sang Ryoul Park, Sook Kyoung Kim
  • Patent number: 9290795
    Abstract: A nucleic acid amplification apparatus for amplifying a target nucleic acid derived from living organism, comprising: a measurement unit for amplifying the target nucleic acid in a measuring sample prepared from the living organism, and measuring a product of the amplification of the target nucleic acid; a measurement value obtaining unit for obtaining a measurement value related to an amount of the product of the amplification; and a judging unit for judging whether amplification inhibition of the target nucleic acid occur or not based on a first measurement value and a second measurement value, the first measurement value obtained from a first measurement sample and the second measurement value obtained from a second measurement sample having a difference dilution ratio from the first measurement sample.
    Type: Grant
    Filed: January 26, 2007
    Date of Patent: March 22, 2016
    Assignee: Sysmex Corporation
    Inventors: Yasumasa Akai, Kadzuki Nakabayashi, Eiji Tanoshima
  • Patent number: 9290817
    Abstract: Three important species of Aspergillus, A. fumigatus, A. flavus and A. niger are known to contribute to the pathogenicity of allergic and invasive diseases in humans. They are also known to be plant pathogens. Several important ESTs/genes of Aspergilli species are now identified and characterized. Efforts are still needed to explore 30% genes of Aspergillus species for their valuable products which need to be explored. Polyketide biosynthetic pathway in Aspergillus species produce important secondary metabolites like polyketide toxins such as Aflatoxins, drugs such as Lovastatins and several other important pharmaceutically important polyketide compounds etc. With the availability of Aspergillus genome sequences it is possible today to characterize the structure and function of important genes of Aspergillus species. Based on the gene sequence information on PKS enzymes in medically and agriculturally important Aspergillus species such as A. fumigatus, A. flavus and A.
    Type: Grant
    Filed: August 12, 2011
    Date of Patent: March 22, 2016
    Assignee: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    Inventors: Preetida Jagdish Bhetariya, Taruna Madan Gupta, Yogendra Singh, Anupam Varma, Puranam Usha Sarma
  • Patent number: 9278356
    Abstract: An attachment unit for attachment of a reaction container including a channel filled with a reaction solution containing a fluorescent probe and a liquid having a specific gravity different from that of the reaction solution and being immiscible with the reaction solution, the reaction solution moving close to opposed inner walls, a first heating unit heating a first region of the channel and a second heating unit heating a second region of the channel when the reaction container is attached to the attachment unit, a drive mechanism switching arrangement of the attachment unit, the first heating unit, and the second heating unit between a first arrangement and a second arrangement in which a lowermost position of the channel is located within a first region and a second region, respectively, a measurement unit measuring light intensity, and a control unit controlling the portions described above.
    Type: Grant
    Filed: March 12, 2013
    Date of Patent: March 8, 2016
    Assignee: Seiko Epson Corporation
    Inventors: Akemi Yamaguchi, Hiroshi Koeda
  • Patent number: 9273362
    Abstract: Provided is a method of detecting or quantifying a wheat species-specific DNA in a test sample by polymerase chain reaction. The method comprises a step of amplifying a nucleic acid molecule having a partial sequence of a nucleotide sequence identified as SEQ ID NO: 1 using a nucleic acid molecule in the test sample or a nucleic acid molecule extracted from the test sample as the template and using a primer pair capable of amplifying the partial sequence and a step of detecting or quantifying the amplified nucleic acid molecule.
    Type: Grant
    Filed: December 17, 2010
    Date of Patent: March 1, 2016
    Assignee: NISSHIN SEIFUN GROUP INC.
    Inventors: Kazumi Kitta, Satoshi Furui, Junichi Mano, Shinjiro Imai, Keiko Tanaka, Yasuyuki Matsuoka, Shinichiro Arami, Megumi Sato, Hiroyuki Haraguchi, Youichi Kurimoto
  • Patent number: 9249465
    Abstract: Molecular markers for lung and colorectal carcinomas and methods of using them in blood sample assays are disclosed. The method comprises measuring the expression of the markers in a blood sample from a subject for detecting the presence and/or severity of lung and/or colorectal cancer, and for monitoring and/or assessing the prognosis of the subject's response to a cancer therapy. Also disclosed are kits for detecting, diagnosing, and/or monitoring lung or colorectal carcinomas.
    Type: Grant
    Filed: August 28, 2009
    Date of Patent: February 2, 2016
    Assignee: Advpharma, Inc.
    Inventors: Harn-Jing Terng, Woan-Jen Lee, Chin-Yu Chen
  • Patent number: 9249472
    Abstract: The disclosed invention is related to methods, compositions, kits and isolated nucleic acid sequences for targeting Adenovirus nucleic acid. Compositions include amplification oligomers and/or detection probe oligomers. Kits and methods comprise at least one of these oligomers.
    Type: Grant
    Filed: March 20, 2014
    Date of Patent: February 2, 2016
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Emily Ziegler, Jessica Townsend
  • Patent number: 9249459
    Abstract: The present invention provides methods for analysis of genomic DNA and/or RNA from small samples or even single cells. Methods for analyzing genomic DNA can entail whole genome amplification (WGA), followed by preamplification and amplification of selected target nucleic acids. Methods for analyzing RNA can entail reverse transcription of the desired RNA, followed by preamplification and amplification of selected target nucleic acids.
    Type: Grant
    Filed: December 10, 2013
    Date of Patent: February 2, 2016
    Assignee: Fluidigm Corporation
    Inventors: Amy Hamilton, Min Lin, Alain Mir, Martin Pieprzyk
  • Patent number: 9243298
    Abstract: The current invention relates to a diagnostic kit for a bacterial species and/or fungal and/or yeast species comprising at least one oligonucleotide probe capable of binding to at least a portion of the LepA and/or Guf1 genes or its corresponding mRNA.
    Type: Grant
    Filed: June 15, 2009
    Date of Patent: January 26, 2016
    Assignee: National University of Ireland, Galway
    Inventors: Thomas Gerard Barry, Majella Maher, Terence James Smith, Justin O'Grady
  • Patent number: 9238844
    Abstract: Methods and kits used in the detection of variants of the Influenza virus are disclosed, including variants that are resistant to treatment with antiviral compositions.
    Type: Grant
    Filed: October 20, 2010
    Date of Patent: January 19, 2016
    Assignees: THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE, ARIZONA BOARD OF REGENTS ON BEHALF OF NORTHERN ARIZONA UNIVERSITY
    Inventors: Paul Keim, David Engelthaler, Elizabeth Driebe, Cindy Liu
  • Patent number: 9228228
    Abstract: The present invention is related generally to analysis of polynucleotides, particularly polynucleotides derived from genomic DNA. The invention provides methods, compositions and systems for such analysis. Encompassed by the invention are arrays of polynucleotides in which the polynucleotides have undergone multiple rounds of amplification in order to increase the strength of signals associated with single polynucleotide molecules.
    Type: Grant
    Filed: February 25, 2011
    Date of Patent: January 5, 2016
    Assignee: Complete Genomics, Inc.
    Inventors: Radoje T. Drmanac, Matthew Callow
  • Patent number: 9217740
    Abstract: A method for identifying mitochondrial heteroplasmy within eukaryotic cells is provided. This method includes means for isolating and capturing a single mitochondrion from at least one eukaryotic cell, wherein the means for isolating and capturing a single mitochondrion further includes optical tweezers or a similar optical technology; means for analyzing the isolated and captured mitochondrion, wherein the means for analyzing the isolated and captured mitochondrion further includes a DNA amplification system and a sequencing system for amplifying and sequencing DNA extracted from the mitochondrion; means for identifying at least one mitochondrial heteroplasmy of interest; and means for using the DNA amplification and DNA sequencing systems to determine the presence or absence of the mitochondrial heteroplasmy within the eukaryotic cell from which the mitochondrion was obtained.
    Type: Grant
    Filed: May 4, 2011
    Date of Patent: December 22, 2015
    Assignee: Gettysburg College
    Inventors: Koren Holland Deckman, Barbara C. Levin, Kristian Helmerson, Rani B. Kishore, Joseph E. Reiner
  • Patent number: 9206478
    Abstract: Methods, compositions, and systems are provided for managing bovine subjects in order to maximize their individual potential performance and edible meat value, and to maximize profits obtained in marketing the bovine subjects. The methods and systems draw an inference of a trait of a bovine subject by determining the nucleotide occurrence of at least one bovine SNP that is identified herein as being associated with the trait. The inference is used in methods of the present invention to establish the economic value of a bovine subject, to improve profits related to selling beef from a bovine subject; to manage bovine subjects, to sort bovine subjects; to improve the genetics of a bovine population by selecting and breeding of bovine subjects, to clone a bovine subject with a specific trait, to track meat or another commercial product of a bovine subject; and to diagnose a health condition of a bovine subject.
    Type: Grant
    Filed: April 25, 2013
    Date of Patent: December 8, 2015
    Assignees: Branhaven LLC, Cargill, Incorporated
    Inventors: Sue K. Denise, Richard Kerr, David Rosenfeld, Tom Holm, Stephen Bates, Dennis Fantin
  • Patent number: 9201063
    Abstract: Methods for detecting a plurality of targets in a biological sample are provided. The method comprises contacting the biological sample with a plurality of target-binding probes simultaneously to form a plurality of target-bound probes and observing the signals from the target-bound probes sequentially. An associated kit and device for detection of the plurality of targets are also provided.
    Type: Grant
    Filed: October 21, 2009
    Date of Patent: December 1, 2015
    Assignee: General Electric Company
    Inventors: Anup Sood, John Richard Nelson, Michael John Gerdes
  • Patent number: 9193991
    Abstract: The present invention provides methods and systems for real-time measurements of PCR with multiplexing capability. Certain embodiments relate to methods and systems that use fluorescently encoded superparamagnetic microspheres for the immobilization of amplification products during the PCR process, and an imaging chamber of a measurement device that is also capable of controllable thermal cycling for assisting the PCR process.
    Type: Grant
    Filed: September 29, 2014
    Date of Patent: November 24, 2015
    Assignee: LUMINEX CORPORATION
    Inventors: Douglas F. Whitman, Charles J. Collins
  • Patent number: 9193999
    Abstract: A method for sequencing includes steps of (a) providing first and second nucleic acid templates, wherein the two templates have different sequences; (b) extending a first primer bound to the first template using a first polymerase species and a first set of nucleotide analogs; (c) extending a second primer bound to the second template using a second polymerase species and a second set of nucleotide analogs, wherein the first polymerase species is different from the second polymerase species and wherein the first set of nucleotide analog is different from the second set of nucleotide analog, (d) detecting the first and second primer extension products; and (e) repeating steps (b) through (d), thereby determining the different sequences of the first and second templates.
    Type: Grant
    Filed: June 25, 2014
    Date of Patent: November 24, 2015
    Assignee: Illumina, Inc.
    Inventors: Martin Maria Fabani, Maria Candelaria Rogert Bacigalupo, John A. Moon
  • Patent number: 9169513
    Abstract: A method including (a) providing an amplification reagent including an array of sites, and a solution having different target nucleic acids; and (b) reacting the amplification reagent to produce amplification sites each having a clonal population of amplicons from a target nucleic acid from the solution. The reacting can include simultaneously transporting the nucleic acids to the sites at an average transport rate, and amplifying the nucleic acids that transport to the sites at an average amplification rate, wherein the average amplification rate exceeds the average transport rate. The reacting can include producing a first amplicon from a nucleic acid that transports to each of the sites, and producing subsequent amplicons from the nucleic acid or from the first amplicon, wherein the average rate at which the subsequent amplicons are generated exceeds the average rate at which the first amplicon is generated.
    Type: Grant
    Filed: October 13, 2014
    Date of Patent: October 27, 2015
    Assignee: ILLUMINA, INC.
    Inventors: Min-Jui Richard Shen, Jonathan Mark Boutell, Kathryn M. Stephens, Mostafa Ronaghi, Kevin Gunderson, Bala Murali Venkatesan, M. Shane Bowen, Kandaswamy Vijayan
  • Patent number: 9150935
    Abstract: This document provides methods and materials for detecting target nucleic acid. For example, methods and materials for detecting the presence or absence of target nucleic acid, methods and materials for detecting the amount of target nucleic acid present within a sample, kits for detecting the presence or absence of target nucleic acid, kits for detecting the amount of target nucleic acid present within a sample, and methods for making such kits are provided.
    Type: Grant
    Filed: November 14, 2013
    Date of Patent: October 6, 2015
    Assignee: Cascade Biosystems, Inc.
    Inventors: Kenneth D. Smith, Nina Yazvenko, Mariya Smit
  • Patent number: 9150920
    Abstract: Embodiments of the invention relate generally to ex vivo methods of quantifying expression of interferon responsive genes and characterizing an individual's potential responsiveness to interferon administration. Certain embodiments relate to methods to monitor the efficacy of ongoing interferon therapy by evaluating expression of interferon responsive genes before and after interferon administration.
    Type: Grant
    Filed: May 3, 2011
    Date of Patent: October 6, 2015
    Assignees: HITACHI CHEMICAL CO., LTD., HITACHI CHEMICAL COMPANY AMERICA, LTD, THE CLEVELAND CLINIC FOUNDATION
    Inventors: Masato Mitsuhashi, Ernest C. Borden
  • Patent number: 9150896
    Abstract: Provided herein is a method of amplifying nucleic acids using a plurality of modified nucleotides one or more of the nucleotides comprising a 3? blocking group. Also provided is a method of amplifying nucleic acids using oligonucleotide primers one or both of the primers comprising a 3? blocking group on one or more of the nucleotides of the primers.
    Type: Grant
    Filed: March 1, 2013
    Date of Patent: October 6, 2015
    Assignee: Illumina, Inc.
    Inventors: Cheng-Yao Chen, Gothami Padmabandu